- The trend backdrop is active with a 13-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
IDIA
EBS
Week ended 07 Aug 2026
Weekly Investor Report
Idorsia Ltd · Healthcare · Biotechnology
Latest close
6.00 CHF
-1.8%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 35.7% above the Trend Line and sits at 79.4% of its 52-week range. The latest completed week returned -1.8%, after a -3.1% four-week move. The latest news-sentiment score is 39/100.
Setup score
69
out of 100
Latest Close
6.00 CHF
7 Aug 2026
1W Return
-1.8%
latest completed week
4W Return
-3.1%
short-term follow-through
12W Return
35.1%
quarterly tape
Trend Breadth
82.7%
43 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.8%
Latest completed week; four-week move -3.1%.
Indicator stack
90/66
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.67%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
39/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 35.7% above the Trend Line and sits at 79.4% of its 52-week range. The latest completed week returned -1.8%, after a -3.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9312-week average 0.73
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.93Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.1% over four weeks, 35.1% over 12 weeks, and 131.4% over one year. The current trend has remained active for 13 consecutive weeks.
Performance by holding period
Active trend streak13 weeks
Active weeks in one year43
Trend breadth82.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.96Latest activity-pressure read.
Pressure change-18.6%Four-week change in activity pressure.
Leadership34.47Latest relative-leadership reading.
RS change-28.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment39/100
Weighted news tone is negative across 11 relevant articles.
1 positive · 7 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-13.4%Distance below the 52-week high.
13-week volatility10.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+25.1%Week of 19 Jun.
Worst week-9.8%Week of 6 Mar.
Latest week-1.8%Week of 7 Aug.
Shape of recent returns
Strong gains11
Modest gains2
Flat weeks0
Modest losses7
Sharp losses6
Recent vol10.1%13-week weekly-return volatility.
Base vol9.4%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew8.7% / -5.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Healthcare
4-week rank29 / 40
Group average2.0%
Trend breadth52.5%
Trend52.5%active weekly trend signals
MD62.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryCH Biotechnology
4-week rank8 / 11
Group average2.2%
Trend breadth36.4%
Trend36.4%active weekly trend signals
MD36.4%positive activity pressure
RS36.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape71/100
Trend, activity pressure, participation, and risk combine to a 71/100 tape read.
Indicator analysis86/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.93; 2 reversal markers Next-Week ExpectancyPositive 55.67%Next-week expectancy is positive with a 55.67% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment39/100Weighted news tone is negative across 11 relevant articles.
Should Idorsia’s (SWX:IDIA) Jamjoom QUVIVIQ Deal and H1 Loss Shift Its Growth Narrative? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 6.00 CHF | -1.8% | 4.43 CHF | 2.62 CHF | 0.96 | 34.47 | 7.5M | On |
| 31 Jul 2026 | 6.12 CHF | -0.8% | 4.35 CHF | 2.62 CHF | 1.07 | 40.54 | 8.6M | On |
| 24 Jul 2026 | 6.17 CHF | 4.5% | 4.29 CHF | 2.62 CHF | 1.10 | 43.07 | 4.7M | On |
| 17 Jul 2026 | 5.90 CHF | -4.8% | 4.23 CHF | 2.62 CHF | 1.17 | 38.44 | 5.9M | On |
| 10 Jul 2026 | 6.20 CHF | -6.5% | 4.17 CHF | 2.63 CHF | 1.17 | 48.19 | 6.1M | On |
| 3 Jul 2026 | 6.63 CHF | -3.4% | 4.10 CHF | 2.63 CHF | 1.05 | 58.87 | 978.7K | On |
| 26 Jun 2026 | 6.86 CHF | 20.9% | 4.00 CHF | 2.62 CHF | 0.86 | 70.31 | 3.2M | On |
| 19 Jun 2026 | 5.67 CHF | 25.1% | 3.88 CHF | 2.62 CHF | 0.80 | 48.13 | 2.4M | On |
| 12 Jun 2026 | 4.54 CHF | 5.5% | 3.80 CHF | 2.63 CHF | 0.68 | 21.08 | 1.2M | On |
| 5 Jun 2026 | 4.30 CHF | -3.8% | 3.75 CHF | 2.66 CHF | 0.74 | 18.84 | 755.8K | On |
| 29 May 2026 | 4.47 CHF | 8.1% | 3.72 CHF | 2.68 CHF | 0.66 | 23.46 | 9.7M | On |
| 22 May 2026 | 4.13 CHF | -7.1% | 3.68 CHF | 2.70 CHF | 0.37 | 16.20 | 9.0M | On |
| 15 May 2026 | 4.45 CHF | 14.3% | 3.66 CHF | 2.73 CHF | 0.14 | 29.40 | 10.7M | On |
| 8 May 2026 | 3.89 CHF | 5.6% | 3.64 CHF | 2.75 CHF | -0.23 | 16.20 | 7.6M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.